Approval for revision of the instructions for administration of trivisc to help prevent any leakage of the product during administration.
Device | TriVisc |
Generic Name | Acid, Hyaluronic, Intraarticular |
Applicant | ORTHOGENRX,INC |
Date Received | 2020-05-08 |
Decision Date | 2020-06-07 |
PMA | P160057 |
Supplement | S001 |
Product Code | MOZ |
Advisory Committee | Orthopedic |
Supplement Type | Special (immediate Track) |
Supplement Reason | Labeling Change - Indications/instructions/shelf Life/tradename |
Expedited Review | No |
Combination Product | No |
Applicant Address | ORTHOGENRX,INC 3805 Old Easton Road doylestown, PA 18902-8400 |
Supplemental Filings
Supplement Number | Date | Supplement Type |
P160057 | | Original Filing |
S001 |
2020-05-08 |
Special (immediate Track) |
NIH GUDID Devices